BIT 5.56% 1.9¢ biotron limited

Ann: BIT225 RESTORES IMMUNE FUNCTION IN HIV-1 INFECTIONS, page-277

  1. 16,461 Posts.
    lightbulb Created with Sketch. 774
    Did anyone actually read this announcement , nothing has been proven from this HIV-1 phase 2 trial , there is only a possibility of an immune effect. Explains why no Pharma is putting up any money up for a phase 3 trial.

    "BIT225’s immune modulating effects MAY have utility in improving HIV-1 induced chronic immune activation outcomes and aid in future eradication strategies."



    Definition of May

    You use MAY to indicate something will possibly happen or be true in the future , but you cannot be certain , vagueness.

 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
1.9¢
Change
0.001(5.56%)
Mkt cap ! $17.14M
Open High Low Value Volume
1.8¢ 1.9¢ 1.8¢ $3.69K 197.6K

Buyers (Bids)

No. Vol. Price($)
5 2175000 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.9¢ 480522 6
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.